Copper Histidine

组氨酸铜

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameCopper Histidine
Drug Alias NameZycuboCUTX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCopper-transporting ATPase 1 modulators
TargetsCopper-transporting ATPase 1
Therapy Area/IndicationsMenkes Kinky Hair Syndrome
Global Approved IndicationsMenkes Kinky Hair Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2026/01/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCyprium Therapeutics IncEunice Kennedy Shriver National Institute Of Child Health And Human Development
China Registration ClassN/A

Develop Information

Active CompaniesSentynl Therapeutics Inc
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentCyprium Therapeutics Inc
Active IndicationsMenkes Kinky Hair Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank